HF
GCVRZ

Hoxton Financial’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Hoxton Financial’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$0 Buy
+2,039
New +$221 ﹤0.01% 392
2015
Q4 		– Sell
-2,039
Closed – – 403
2015
Q3 		$0 Hold
2,039
– – ﹤0.01% 397
2015
Q2 		$1K Hold
2,039
– – ﹤0.01% 341
2015
Q1 		$1K Hold
2,039
– – ﹤0.01% 327
2014
Q4 		$2K Hold
2,039
– – ﹤0.01% 314
2014
Q3 		$1K Hold
2,039
– – ﹤0.01% 319
2014
Q2 		$1K Hold
2,039
– – ﹤0.01% 313
2014
Q1 		$1K Hold
2,039
– – ﹤0.01% 330
2013
Q4 		$1K Buy
+2,039
New +$2.46K ﹤0.01% 693
2013
Q3 		– Sell
-2,039
Closed -$4K – 704
2013
Q2 		$4K Buy
+2,039
New +$3.58K ﹤0.01% 534

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Hoxton Financial's GCVRZ Position: Q1 2016 in Review

Hoxton Financial opened a new position in Sanofi Contingent Value Rights (GCVRZ) in Q1 2016: 2,039 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #392 among its holdings. This is a return to the name: Hoxton Financial previously reported a position in GCVRZ as recently as Q3 2015.

Hoxton Financial first reported a position in GCVRZ in Q2 2013 and has held it in 10 quarters since. The position peaked at $4K in Q2 2013. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2016.

  • Hoxton Financial held 2,039 shares of Sanofi Contingent Value Rights worth $0 as of Q1 2016.
  • Sanofi Contingent Value Rights was a new Hoxton Financial position in Q1 2016.
  • Sanofi Contingent Value Rights made up ﹤0.01% of Hoxton Financial's portfolio in Q1 2016, its #392 holding.
  • Hoxton Financial first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 10 quarters since.
  • Hoxton Financial's Sanofi Contingent Value Rights position peaked at $4K in Q2 2013.
  • 106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.